Although malignancy-associated EMT is controlled by a variety of biological pathways, NF-κB signaling is activated in a wide range of human cancers, and is involved in maintaining epithelial cell plasticity and metastasis via the orchestrated modulation of IKK-2/IκBα/NF-κB [26]. The gene discussed is NFKB1; the disease is cancer.